JP Patent

JP2016523916A — 安定な液体製剤

Assigned to Amgen Inc · Expires 2016-08-12 · 10y expired

What this patent protects

カルシウム感知受容体のペプチド作動薬を含む液体製剤ならびに該製剤の製造方法および使用方法を提供する。

USPTO Abstract

カルシウム感知受容体のペプチド作動薬を含む液体製剤ならびに該製剤の製造方法および使用方法を提供する。

Drugs covered by this patent

Patent Metadata

Patent number
JP2016523916A
Jurisdiction
JP
Classification
—
Expires
2016-08-12
Drug substance claim
No
Drug product claim
No
Assignee
Amgen Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.